This October, Neuroendocrine Cancer’s Catherine Bouvier attended the 3rd IPCO Forum for Theranostics in Precision Oncology in Munich. With leading experts from India, China, Middle East, the US & Canada, the conference recognised the Paradigm Shift to Precision Oncology and the new options for our Neuroendocrine Cancer community.

The 3rd ICPO Forum for Theranostics in Precision Oncology (still widely known to patients as PRRT) discussed important developments in implementing a more effective patient-centered focus around new Radio Theranostics technologies.

Mark McDonnell (INCA President) highlighted unmet needs globally for access and availability in theranostics – a prominent theme at the conference. There is no room for fragmented care.

“Excellence in science needs to equal excellence in access and follow-up care”

Josh Mailman discussed the variance in opinions and the importance of global theranostics education.

“Are our health systems ready for the rapid growth in theranostics? There will be challenges and complexities we must not ignore.”